| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |